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Whereas, bacterial inclusion bodies (IBs) for long were regarded as undesirable
aggregates emerging during recombinant protein production, they currently receive
attention as promising nanoparticulate biomaterials with diverse applications in
biotechnology and biomedicine. We previously identified ssTorA, a signal sequence that
normally directs protein export via the Tat pathway in E. coli, as a tag that induces the
accumulation of fused proteins into IBs under overexpression conditions. Here, we used
targeted mutagenesis to identify features and motifs being either critical or dispensable
for IB formation. We found that IB formation is neither related to the function of ssTorA
as a Tat-signal sequence nor is it a general feature of this family of signal sequences. IB
formation was inhibited by co-overexpression of ssTorA binding chaperones TorD and
DnaK and by amino acid substitutions that affect the propensity of ssTorA to form an
α-helix. Systematic deletion experiments identified a minimal region of ssTorA required for
IB formation in the center of the signal sequence. Unbiased genetic screening of a library
of randomly mutagenized ssTorA sequences for reduced aggregation properties allowed
us to pinpoint residues that are critical to sustain insoluble expression. Together, the data
point to possible mechanisms for the aggregation of ssTorA fusions. Additionally, they
led to the design of a tag with superior IB-formation properties compared to the original
ssTorA sequence.
Keywords: inclusion bodies, fusion tag, insoluble expression, protein aggregation, heterologous protein
production, signal peptide, twin-arginine translocation pathway, chaperone
INTRODUCTION
Heterologous proteins that are overexpressed in microbial hosts such as E. coli often accumulate
in insoluble clusters called inclusion bodies (IBs). The IBs preferentially localize at the poles of
the bacteria, which is thought to be related to the accumulation of dense DNA central in the cells.
The IBs vary in size from 0.1 to 1µm and although their chemical composition may vary, they
consist predominantly of the overexpressed recombinant protein (Ramon et al., 2014; de Marco
et al., 2019). Traditionally, IB formation is linked to the aggregation of misfolded polypeptides and
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seen as an obstacle in production processes aimed at high yields
of soluble, active protein species. To avoid aggregation several
strategies have been explored including lowering of transcription
and translation rates, reduction of the growth temperature and
co-expression of chaperones that assist in proper folding (Kaur
et al., 2018). Alternatively, IBs can be isolated, denatured and
subjected to refolding conditions to regenerate the active protein
(Yamaguchi and Miyazaki, 2014; Singh et al., 2015).
Rather than being regarded as an undesirable side effect
of industrial protein production, the generation of IBs is
now increasingly appreciated as a useful strategy to obtain
recombinant protein. Proteins in IBs are largely resistant against
degradation by host cell proteases and less likely to exert toxic
effects in the expression host. In addition, owing to their high
density, IBs are easy to isolate from cell lysates by differential
centrifugation, providing robust and cost-efficient protocols to
obtain large amounts of relatively pure protein (Swartz, 2001;
Sahdev et al., 2008; Martinez-Alonso et al., 2009). Moreover,
whereas IBs for long were considered to be amorphous aggregates
of disordered protein, they actually display a structured β-sheet
organization and can contain significant amounts of protein in
a native conformation. This makes them interesting as a supply
of nanostructured biomaterial with high mechanical stability,
biological activity and slow protein release properties. These IBs
may for example be exploited as immobilized reusable catalysts
in biotechnology or as “nanopills” for the delivery of therapeutics
and vaccines in biomedicine (Ramon et al., 2014; de Marco et al.,
2019).
Unfortunately, the formation of IBs, approaches to prevent
their formation and conditions for refolding proteins from
IBs are difficult to predict and need to be evaluated and
addressed on a case-to-case basis. Different parameters may
impact aggregation such as the extent and kinetics of induced
expression, culture conditions (temperature, growth rate, pH)
and the presence or absence of folding modulators in the
host strain. The same parameters may also affect the size of
the inclusion bodies, their physical properties and the balance
between denatured and native protein (Rinas et al., 2017; Slouka
et al., 2019).
To increase the yield of inclusion bodies and allow a
more robust and predictable workflow, fusion tags have been
developed that induce aggregation of the recombinant protein.
A well-known example is the strongly hydrophobic ketosteroid
isomerase sequence (Kuliopulos and Walsh, 1994) that is
commercially available in the pET31b expression vector. Other
examples include trp1LE (Derynck et al., 1984), β-galactosidase
(Schellenberger et al., 1993), PagP (Hwang et al., 2012), EDDIE
(Achmuller et al., 2007), ELK16 (Wu et al., 2011), GFIL8 (Wang
et al., 2015), PaP3.30 (Rao et al., 2004), TAF12-HFD (Vidovic
et al., 2009), and the F4 fragment of PurF (Lee et al., 2000). Most
described tags comprise relatively large sequences (Derynck et al.,
1984; Schellenberger et al., 1993; Kuliopulos andWalsh, 1994; Lee
et al., 2000; Rao et al., 2004; Achmuller et al., 2007; Hwang et al.,
2012) that may adversely affect the yield of the target protein
or compromise downstream applications. Smaller IB-tags have
been presented but were only used for the production of short
polypeptides (Vidovic et al., 2009) or the functionality of the tag
was difficult to evaluate (Cook et al., 2011; Wu et al., 2011; Zhou
et al., 2012; Wang et al., 2015).
Previously, we have serendipitously found that the 39-amino
acid signal sequence of E. coli TMAO-reductase (ssTorA)
functions as a small and robust, versatile fusion tag that promoted
IB formation of any polypeptide it was fused to, ranging
from small human hormones to very large bacterial secretory
proteins. Interestingly, fusion to GFP yielded fluorescent
aggregates, alluding to a compatibility of ssTorA with the
production of bioactive IBs. Evidence was further obtained that
multiple ssTorAs fused in tandem either at the N-terminus,
C-terminus or both, can mediate complete aggregation of
even very soluble cargo proteins such as maltose binding
protein (Jong et al., 2017).
In this study we investigated the minimal requirements and
mechanism by which ssTorA, a peptide that is not particularly
hydrophobic and normally triggers transport of folded proteins
across the bacterial inner membrane via the twin-arginine
translocation (Tat) pathway (Sargent, 2007), achieves robust
induction of inclusion body formation. We identified a region
central in ssTorA that is critical for IB formation. In fact, a
shortened IB-tag based on this information provoked increased
expression and IB formation compared to the original ssTorA.
Further studies pointed to the importance of specific residues in
ssTorA and the role of specific and generic chaperones in ssTorA
induced IB formation.
MATERIALS AND METHODS
Strains, Media, and Growth Conditions
Escherichia coli K-12 strain TOP10F
′
(Invitrogen, UK) and
MC4100 (Casadaban, 1976) were used for plasmid-based protein
expression. MC41001tatA/E (Sargent et al., 1998) was used
when indicated. When grown in culture, cells were grown in
LB medium in a shake incubator in the presence of ampicillin
(100µg/ml). Cultures of cells containing pOFX-tac (derivative)
plasmids also contained kanamycin (50µg/ml) and glucose
(0.2%). Cultures were grown at 37◦C in tubes or flasks in a
shake incubator (200 rpm) using a 5:1 tube/flask:culture volume
ratio. Growth on solid medium was performed at 37◦C making
use of LB-agar (1.5%) plates supplemented with ampicillin
(100µg/ml). Plates also contained chloramphenicol (30µg/ml)
if indicated.
Reagents
The Rapid Dephos & Ligation Kit was obtained from Roche
Applied Science. Phusion High Fidelity DNA polymerase was
purchased from New England Biolabs (New England Biolabs;
NEB). Low fidelity DNA polymerase Pfu-Pol(exo−) D473G
(Biles and Connolly, 2004) was obtained as a kind gift from
B. Connolly (University of Newcastle, Newcastle upon Tyne,
UK). DNA restriction enzymes were purchased from Roche
or NEB. Anhydrotetracyclin was from IBA GmbH. Isopropyl
β-D-1-thiogalactopyranoside (IPTG) as purchased from Bioline
Reagents Ltd. Lysozyme and all other chemicals were purchased
from Sigma Aldrich.
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Plasmid Construction
The plasmids and primers used in this study can
be found in Supplementary Tables 2, 3, respectively.
Details on plasmid construction can be found as
Supplementary Materials and Methods.
General Protein Expression and Analysis
Plasmid-based protein expression was induced using
anhydrotetracycline (0.2µg/ml) when cell cultures reached
an OD660 of ∼0.3. For analysis, cells and cell-fractions were
resuspended in SDS-sample buffer (125mM Tris–HCl pH 6.8,
4% SDS, 20% glycerol, 0.02% bromophenolblue, 83mM DTT)
and incubated at 96◦C for 10min. Proteins were analyzed by
SDS-PAGE and Coomassie Brilliant Blue G (Jansen Chimica)
staining. Commercial Bis–Tris NuPAGE (Invitrogen) or
TGX gels (Biorad) were used where appropriate. Imaging
of Coomassie-stained gels was carried out using a GS-800
densitometer (Biorad) in combination with Quantity-One
software (Biorad).
IB Sedimentation Assay
To separate IBs from the soluble cell content, a culture volume
containing the number of cells that gives an OD660 of 1.5
in a 1ml suspension was subjected to centrifugation. The
pelleted intact cells were resuspended in 750 µl ice-cold lysis
buffer (5mM Tris–HCl, pH 7.6, 1mM EDTA, 100mM NaCl).
Lysozymewas added to a final concentration of 17 ng/ml and cells
were incubated on ice for 15min. Subsequently, the cells were
disrupted by freeze thawing and tip sonication (Branson Sonifier
250). The resulting lysate was centrifuged (4,500×g, at 4◦C for
10min) to sediment IBs and other dense, insoluble material.
The resulting pellet was subjected to SDS-PAGE analysis directly,
whereas the supernatant was trichloroacetic acid precipitated
first. Intact cells directly subjected to SDS-PAGE analysis served
as a control for total cell content.
Phase-Contrast Microscopy
For microscopy analysis, cells were fixed in-culture with
formaldehyde (3%) at room temperature for 15min, collected
by low-speed centrifugation and re-suspended in PBS. Cells were
then photographed with an Olympus F-view II camera mounted
on an Olympus 5 BH-2 microscope through a DApo100UV PL
1.30 oil 160/0.17 objective.
qPCR
Cells carrying either pIBA-ssTorA/TrxA, pIBA-ssTorA(15–
9)/TrxA, or pIBA-ssTorA(15–34)/TrxA were induced with
anhydrotetracycline for 1 h. Total RNA was isolated from 1.5
OD660 units of cells using the RNeasy Mini kit (Qiagen),
RNAprotect Bacteria reagent (Qiagen) and DNaseI treatment
(Qiagen) according to manufacturer’s protocols. For quantitative
PCR (qPCR), we used an iCycler and SYBR green Supermix
(Bio-Rad, Hercules, CA, US). Expression of trxA in each
sample was analyzed in duplicates, and expression levels were
normalized to the expression of bla gene present as an antibiotic
resistance marker on the pIBA vector backbone. Primer pairs
used were qPCR TrxA fw/qPCR TrxA rv and qPCR bla fw/qPCR
bla rv both yielding∼160 bp products.
ssTorA Random Mutagenesis Library
To create a library of randomly mutagenized DNA encoding
ssTorA, error-prone PCR was carried out using Pfu(exo−)
D473G polymerase, Pfu ultra HF reaction buffer (Agilent),
600µM of dNTPs and 20mM of added MgSO4. Plasmid
pIBA-ssTorA/TrxA (Jong et al., 2017) was used as the template
and the primers were ssTorA mut fw and ssTorA mut rv.
The PCR product was XbaI/NheI digested and the resulting
ssTorAmut fragment–encoding residues 1–36 of ssTorA and
the upstream Shine-Dalgarno sequence of the template—
was ligated to the corresponding sites of pIBA-ssTorA/CAT.
Following electroporation of the ligation mixture into E. coli
TOP10F
′
cells, bacterial colonies were scrape-harvested from
LB-agar plates containing ampicillin and pooled. The resulting
cell material was suspended in LB with glycerol (12%) to
establish a TOP10F
′
(pIBA-ssTorAmut/CAT) library. Prior to
harvesting, plasmid DNA from individual colonies was subjected
to DNA sequencing and a mutation rate of 1–5 mutations
per ssTorA encoding fragment was established for 90% of the
pIBA-ssTorAmut/CAT ligation products.
Chloramphenicol Survival Screening and
MiSeq Sequencing
Liquid medium was inoculated with part of the
TOP10F
′
(pIBA-ssTorAmut/CAT) library cell suspension to
an OD660 of 0.05 and incubated at 37
◦C with shaking. When
the culture reached an OD660 value of 0.3 cells were induced for
expression of ssTorAmut/CAT by addition of anhydrotetracycline
(0.2µg/ml) and growth was continued. After 2 h samples were
withdrawn from the culture and spread on solid medium with
or without chloramphenicol (30µg/ml), respectively, and the
resulting plates were incubated at 37◦C. To allow comparison
of mutational loads in cells grown in the presence or absence
of selective pressure, similar numbers of colonies (10,000 and
16,000 CFUs) were harvested from plates with and without
chloramphenicol. For either condition, colonies that formed
overnight were scrape-harvested and pooled. Plasmid DNA
was isolated (GeneJet, ThermoFisher Scientific) from 5 OD660
units of cells of either suspension as well as from 5 OD660
units of original TOP10F
′
(pIBA-ssTorAmut/CAT) library
cells not subjected to the chloramphenicol survival assay.
Using the respective plasmid isolates as a template, a 222 bp
fragment including the ssTorA region of interest was PCR
amplified using primers ssTorA MiSeq fw and ssTorA MiSeq rv.
Following QIAquick gelextraction (Qiagen, Hilden, Germany)
the amplicons were purified using the Agencourt AMPure XP
PCR Purification system (Beckman Coulter, Pasadena, CA, US)
and the resulting starting DNA library was quantified using
the Qubit dsDNA BR Assay system (Invitrogen, Carlsbad,
CA, US). The sequencing library construction was performed
according to the TruSeq Nano DNA sample prep kit (Illumina,
San Diego, CA, US). The barcoded libraries were subsequently
mixed in equimolar amounts. The multiplexed library pool was
spiked with 40% PhiX control to improve base calling during
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sequencing and was loaded at 7.5 pM. Sequencing was conducted
using a paired-end, 2 × 250-bp cycle run on an Illumina MiSeq
sequencing system and MiSeq Reagent Kit V2 (500 Cycle)
chemistry. After sequencing was complete, image analysis, base
calling, and error estimation were performed using Illumina
Real-Time Analysis software (version 2.2.0.2).
RESULTS
The Relationship Between the Tat Pathway
and IB Formation
We previously found the Tat signal sequence of TorA (ssTorA) to
function as an inclusion body (IB) tag (Figure 1A) when fused to
a cargo protein and expressed at high levels (Jong et al., 2017). To
determine whether this capacity is related to its function as a Tat
signal sequence, we substituted the twin arginine motif (RR) of
ssTorA that is essential for export via the Tat translocon by a non-
conservative alanine pair (RR/AA) (Supplementary Table 1).
The resulting ssTorA mutant was fused to TrxA that is soluble
in E. coli even at high concentrations (LaVallie et al., 1993;
Jong et al., 2017). IB formation of the fusion proteins was
analyzed using an IB sedimentation assay. Briefly, E. coli cells
expressing the fusion constructs were broken and the lysate was
subjected to low-speed centrifugation to separate the dense cell
material including IBs from the soluble proteins. The resulting
fractions and corresponding whole-cell lysate samples were
analyzed by SDS-PAGE and Coomassie staining (Figure 1B).
As we demonstrated previously (Jong et al., 2017), the native
ssTorA sequence drives efficient IB formation, as evident from
the presence of the majority of the ssTorA/TrxA fusion in the
low-speed pellet (Figure 1B, lane 2). The RR/AA substitution
did not affect the amount of fusion protein in the low speed
pellet (Figure 1B, c.f. lane 5 and 2), suggesting that Tat-mediated
targeting is not a prerequisite for the functioning of ssTorA
as an IB formation tag. Moreover, we expressed ssTorA/TrxA
in a strain that lacks the key Tat translocon components TatA
and TatE (Sargent et al., 1998). Also in this genetic background,
most ssTorA/TrxA fusion protein ended up in the low speed
pellet (Figure 1C, lane 2). Together, the data show that ssTorA-
mediated IB formation does not require a functional Tat pathway.
To analyze whether the capacity to induce IB formation is a
universal feature of Tat signal sequences, a panel of these was
selected for fusion to TrxA. The panel represents a cross-section
of E. coli Tat signal sequences, ranging from relatively short
sequences (e.g., ssCueO, 28 aa) to long ones (ssYagT, 53 aa),
and including sequences known to bind a cognate chaperone
(ssTorA, ssDmsA, FdnG, ssHyaA, ssHybO, NapA) (Chan et al.,
2009) and ones that do not (Supplementary Table 1). Despite
being cloned in the same expression context, the various
signal sequences affected expression differently (Figure 2A).
Three chimeras did not show detectable levels of expression
(ssFdnG, ssHybO, ssNapG). Another six showed reduced levels
compared to the ssTorA/TrxA benchmark (AmiC, ssHyaA,
ssNapA, ssWcaM, ssYbaK, ssYagT) whereas two yielded high
levels of expression, comparable to the ssTorA/TrxA (ssCueO,
ssDmsA). The origin of these differences is unclear, but seems
FIGURE 1 | Influence of a functional Tat-system on IB-formation by ssTorA.
(A). Amino acid sequence of the ssTorA IB formation tag. The consensus
sequence containing a twin-arginine pair (bold) that is conserved among
Tat-signal sequences is shaded (Berks, 1996). The basic N-region,
hydrophobic H-region and polar C-region, which are common for signal
sequences (von Heijne, 1985), are indicated below the amino acid sequence
(Cristobal et al., 1999). A serine residue that replaces a native threonine in
ssTorA (Jong et al., 2017) is underlined. (B) IB sedimentation assay on E. coli
TOP10F
′
cells expressing a TrxA fusion carrying wild-type ssTorA as displayed
under A or derivative ssTorA(RR/AA). Cells were lysed and subjected to
differential centrifugation to separate the inclusion bodies (IB)-containing
insoluble fraction from the soluble cell fraction (S). Samples of both fractions
and corresponding whole cell (WC) samples were analyzed by SDS-PAGE and
Coomassie staining. All samples were derived from the same amount of cell
material. (C) IB-sedimentation assay on MC41001tatA/E cells expressing
ssTorA/TrxA as described under B. Bands representing ssTorA/TrxA fusions of
interest are indicated (). Molecular mass (kDa) markers are indicated at the
left side of the panels.
unrelated to length or chaperone binding. Next, we selected
TrxA fusions of two chaperone binding (ssDmsA and ssHyaA)
and two non-chaperone binding signal sequences (ssCueO and
ssWcaM) for analysis of IB formation (Figure 2B). TrxA fused
to ssDmsA, ssHyaA, and ssWcaM was predominantly found in
the soluble fraction in contrast to ssCueO/TrxA that appeared
in the insoluble IB fraction similar to ssTorA/TrxA (Figure 2B,
lane 11). The IB induction by ssCueO is surprising as it
shares no obvious features with ssTorA. In comparison, ssDmsA
seems more closely related to ssTorA with respect to length,
hydrophobicity and chaperone binding (Tullman-Ercek et al.,
2007; Shanmugham et al., 2012). In conclusion, the features that
determine the IB formation capacity of ssTorA are not inherent
to all Tat signal sequences.
Involvement of Cytosolic Chaperones
In native E. coli cells ssTorA functions as a signal sequence
to trigger targeting and translocation of TMAO reductase
(TorA) via the Tat export pathway (Sargent, 2007). A dedicated
cytoplasmic chaperone TorD is co-expressed with TorA when
TMAO is present in the medium (Mejean et al., 1994). TorD
interacts with ssTorA and co-ordinates the export of the
reductase by preventing its premature targeting to the bacterial
inner membrane (Hatzixanthis et al., 2005). In our assays,
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FIGURE 2 | IB formation upon fusion to a panel of Tat signal sequences. (A)
SDS-PAGE/Coomassie staining analysis on cells overexpressing TrxA fused to
a panel of different Tat-signal sequences as indicated. (B) IB-sedimentation
assay as described in the legend to Figure 1 on cells expressing a selection of
the signal sequence/TrxA fusions from A. Bands representing signal
sequence/TrxA fusions of interest are indicated (). Molecular mass (kDa)
markers are indicated at the left side of the panels.
constructs are expressed under conditions of low availability
of TorD as no TMAO is added to the growth medium. We
therefore considered the possibility that the lack of TorD
plays a role in the aggregation of fusions carrying ssTorA. To
investigate this, ssTorA/TrxA was produced in cells already
expressing high-levels of TorD from a compatible expression
plasmid (Figure 3A). Under these co-expression conditions the
fusion protein was still efficiently produced but recovered almost
exclusively from the soluble cell fraction (Figure 3A, lane 6).
In contrast, control cells not induced for TorD expression
produced similar amounts of ssTorA/TrxA but located in the
insoluble fraction as before (Figure 3A, lane 2). Apparently,
overexpressed TorD binds to ssTorA and precludes ssTorA/TrxA
IB formation.
Previously, it was shown that ssTorA also interacts with
the generic cytosolic chaperone DnaK (Oresnik et al., 2001).
Accordingly, using the LIMBO algorithm (Van Durme et al.,
2009) DnaK binding sites were predicted for ssTorA at residues
12–18 (RRFLAQL) and 30–36 (SLLTPRR). To investigate
whether a disbalance between DnaK and ssTorA under the
overexpression conditions used may influence the aggregation
process, we monitored IB-formation upon co-overexpression
of the chaperone. To this end, ssTorA/TrxA was produced in
cells that also express high levels of plasmid-encoded DnaK
and its co-chaperone DnaJ (Figure 3B). Insoluble production of
ssTorA/TrxA could be confirmed in control cells carrying either
an empty co-expression plasmid (Figure 3B, lane 2) or in cells
FIGURE 3 | IB formation upon overexpression of chaperones. (A) IB
sedimentation assay on cells co-transformed with pIBA-ssTorA/TrxA and
pLysTac-TorD as described in the legend to Figure 1. Thirty minutes prior to
induction of expression of ssTorA/TrxA IPTG was added to half of the culture
to induce overexpression of TorD (lanes 4–6). The other half of the culture was
left without IPTG (lanes 1–3). (B) IB sedimentation assay on cells
co-transformed with pIBA-ssTorA/TrxA and either pOFX-tac1-DnaK/DnaJ
(lanes 4–6) or pOFX-tac-MBP (lanes 7–9). Thirty minutes prior to induction of
expression of ssTorA/TrxA IPTG was added to the respective cultures to
induce overexpression of DnaK/DnaJ (lanes 4–6) or MBP (lanes 7–9). Cells
co-transformed with pIBA-ssTorA/TrxA and the empty vector pOFX-tac1
served as a negative control for co-overexpression (lanes 1–3). Bands
representing ssTorA/TrxA fusions of interest are indicated (). Molecular mass
(kDa) markers are indicated at the left side of the panels.
co-overexpressing the unrelated maltose binding protein (MBP)
(Figure 3B, lane 8). In contrast, a strongly reduced amount
of insoluble ssTorA/TrxA was recovered from cells expressing
excess amounts of DnaK/J (Figure 3B, lane 5), indicating
impaired IB formation under these conditions. Conceivably, like
TorD, DnaK associates with ssTorA and interferes with the
aggregation process.
Regions Critical for IB Formation
We next focused on sequence motifs and regions not related
to the Tat system that influence IB formation by ssTorA. The
triple asparagine sequence (NNN) directly downstream of the
initiator methionine (Supplementary Table 1) was considered
Frontiers in Bioengineering and Biotechnology | www.frontiersin.org 5 January 2020 | Volume 7 | Article 442
Jong et al. Characterizing and Improving IB Formation
potentially important because prions typically possess a region
rich in asparagine and/or glutamine residues that enhances their
aggregation (Du, 2011). Initially we substituted the asparagine
residues by alanine residues. However, this modification was
found to impair expression (data not shown), possibly due to the
codon usage in the encoding mRNA. Whereas, in prokaryotes
A/T-rich codons are preferred around the start of the coding
sequence, alanine codons intrinsically have a high G/C-content,
which may interfere with efficient translation initiation and
expression (Kozak, 2005). To prevent impaired expression, the
NNN motif was substituted with a KTK sequence as present
in ssDmsA (Figure 4A; Supplementary Table 1) that sustained
high expression levels upon fusion to TrxA but without inducing
IB formation (Figure 2). With the NNN/KTK substitution
incorporated, expression and IB formation of ssTorA/TrxA was
on par with the wild-type ssTorA/TrxA (Figure 4A). Vice versa,
replacement of the KTKmotif of ssDmsA byNNNdid not induce
insoluble expression of ssDmsA/TrxA fusion (data not shown).
Together, the data indicate that the NNN sequence in ssTorA is
neither required nor sufficient for IB formation. The presence of
A/T rich codons at the start of ssTorA seems important to achieve
high-level expression, which likely is a prerequisite for efficient
IB formation.
Rather than mutating individual motifs in ssTorA, we next
applied an unbiased deletion strategy to identify sequences that
are critical for IB formation. We set out making deletions
based on the natural N-H-C domain structure of the signal
sequence (see Figure 1A). The basic N-domain of ssTorA
(AA 2–13) was removed, leaving the C-terminal domain with
hydrophobic core and polar C-domain intact [ssTorA(C
′
)]
(Supplementary Table 1). Alternatively, we kept the N-domain
intact and removed the C-terminal part of ssTorA (except
C-terminal ASA; AA 14–36)[ssTorA(N
′
)]. A TrxA fusion
carrying ssTorA(N
′
) was exclusively expressed in the soluble
fraction (Figure 4B, lane 9). In contrast, ssTorA(C
′
)/TrxA
accumulated in IBs (Figure 4B, lane 5), although the yield
appeared relatively low for this construct due to reduced
expression (Figure 4B, c.f. lanes 4 and 1). In an attempt to
enhance the expression of ssTorA(C
′
)/TrxA we reinserted the
N-terminal NNN motif (Supplementary Table 1), the codon
usage of which appeared favorable for translation initiation
(see above). Indeed, improved expression of the resulting
ssTorA(C
′
+NNN)/TrxA chimera was observed restoring the IB
yield to the level of ssTorA/TrxA (Figure 4C, c.f. lanes 4–5 and
1–2). In conclusion, the C-terminal part of ssTorA (AA 14–39)
appears sufficient for induction of IB formation.
To further narrow down the regions important for IB
formation, we followed a strategy in which incremental
parts of ssTorA in the ssTorA/TrxA construct were deleted,
starting from the N- and C-terminus, respectively. The set
of N-terminal deletion mutants started at position 5 to keep
the NNN motif at position 2–4 intact for optimal expression.
The number of deleted residues increased by 5 for each
FIGURE 4 | IB formation upon substitution of the NNN motif in ssTorA. IB sedimentation assay as described in the legend to Figure 1 on cells expressing: (A)
ssTorA/TrxA (wild-type) or ssTorA(NNN/KTK)/TrxA, (B) ssTorA/TrxA (wild-type), ssTorA(C
′
)/TrxA, or ssTorA(N
′
)/TrxA, and (C) ssTorA/TrxA (wild-type),
ssTorA(C
′
+NNN)/TrxA or ssTorA(C
′
)/TrxA. Bands representing ssTorA/TrxA fusions of interest are indicated (). Molecular mass (kDa) markers are indicated at the left
side of the panels.
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consecutive mutant (Supplementary Table 1). Remarkably,
whereas fusions carrying deletions up to residue 9 or extending
beyond residue 29 were efficiently expressed (Figure 5A,
lanes 1–2, 6–9), versions with deletions 15–14, 15–19,
and 15–24 were hardly detectable in whole cell lysates by
SDS-PAGE (Figure 5A, lanes 3–5). To investigate whether the
poor expression was due to problems at the mRNA level, we
performed quantitative PCR using trxA-targeting primers to
determine the levels of mRNA encoding the non-detectable
ssTorA(15–19)/TrxA vs. the strongly expressed ssTorA/TrxA
and ssTorA(15–34)/TrxA (Supplementary Figure 1). A
considerable reduction in encoding mRNA was observed
specifically for ssTorA(15–19)/TrxA, which might suggest
that deletions 15–14, 15–19 and 15–24 introduce mRNA
instability, explaining their poor expression. The highly
expressed constructs were analyzed for IB formation as before.
In line with the above observation that the N-terminal part of
ssTorA is dispensable for the production of IBs (see Figure 5A),
insoluble expression was observed for ssTorA(15–9)/TrxA
(Figure 5B, lane 5). In contrast, fusions carrying deletions
15–29,15–34 or15–39 were soluble (Figure 5B, lanes 9,12,15).
It follows that a region critical for the induction of IBs must be
localized downstream of residue 9 and upstream of residue 29
of ssTorA.
A similar deletion strategy was applied on ssTorA but now
starting from the C-terminus. Leaving the C-terminal ASA motif
intact, we removed residues 36 to 17 by deleting three or four
residues per consecutive mutant (Supplementary Table 1;
Figure 6A). Efficient expression was now found for all
ssTorA/TrxA mutants allowing analysis of IB formation.
Deletions up to proline 29 of ssTorA (129–36) did not interfere
with IB formation (Figure 6A, lane 8) whereas derivatives with
larger deletions were completely soluble (Figure 6A, lanes 11,
14, 17). Next, the largest N- and C-terminal deletions that
still formed IBs were combined in one ssTorA/TrxA construct
(Supplementary Table 1) and tested (Figure 6B). Indeed,
ssTorA(15–9/129–36) still induced IB formation to a similar
extent as ssTorA(15–9) (Figure 6B, c.f. lane 11 and 5) but
less efficiently than the intact ssTorA sequence (Figure 6B,
lane 2). This suggests that residues 5–9 are not required for IB
formation per se, but do enhance aggregation. Together, the data
limit the region of ssTorA required for IB formation roughly to
residues 10–28.
Features of ssTorA Involved in IB
Formation
Given the importance of residues 10–28 that roughly correspond
to the hydrophobic H-domain of ssTorA (AA 14–32) (Cristobal
et al., 1999), a potential scenario for the initiation of IB
formation would involve hydrophobic interactions between
neighboring ssTorA sequences or between ssTorA and fused
FIGURE 5 | IB formation upon incremental deletion from the N-terminus of ssTorA. (A) SDS-PAGE/Coomassie staining analysis on cells overexpressing TrxA fused to
wild-type ssTorA or an ssTorA variant carrying any of the indicated amino acid deletions. Expression of TrxA not fused to any ssTorA moiety is labeled 11–39. (B)
IB-sedimentation assay as described in the legend to Figure 1 on cells expressing a selection of the ssTorA/TrxA fusions from A. Bands representing signal
sequence/TrxA fusions of interest are indicated (). Molecular mass (kDa) markers are indicated at the left side of the panels.
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FIGURE 6 | IB formation upon C-terminal and combined N/C-terminal deletions. (A,B) IB-sedimentation assay as described in the legend to Figure 1 on cells
expressing TrxA fused to wild-type ssTorA or an ssTorA variant carrying any of the indicated amino acid deletions. Expression of TrxA not fused to any ssTorA moiety is
labeled 11–39. Bands representing signal sequence/TrxA fusions of interest are indicated (). Molecular mass (kDa) markers are indicated at the left side of the panels.
cargo proteins. However, the hydrophobicity of ssTorA is
relatively modest and similar or lower than that of other
Tat signal sequences that did not form IBs (Tullman-Ercek
et al., 2007) (see Figure 2). Alternatively, the tendency of
signal sequence H-domains to attain an α-helical conformation
was considered. Indeed, substitution of Ala16 in the core of
ssTorA by a proline (A16P) prevented insoluble expression
of ssTorA/TrxA (Supplementary Figure 3B, c.f. lanes 2 and
5), suggesting that α-helix formation is a prerequisite for IB
formation. Interestingly, helical wheel representation of the
ssTorA revealed a concentration of hydrophobic residues at one
side of the helix (F7-F14-L18-L21) (Supplementary Figure 3A,
boxed). Non-conservative substitution of either one (F14 > S14)
or two (F7 > A7 + F14 > S14) of these residues reduced the
amount of ssTorA/TrxA recovered in the insoluble cell fraction
(Supplementary Figure 3C, lanes 5 and 8), suggesting the
importance of this feature in IB formation. Possibly, the imposed
clustering of hydrophobic residues nucleates the assembly of
fusion proteins into IBs.
Screening for Residues Critical for IB
Formation
To identify residues important for IB induction in a
more unbiased way, we developed a library screen with
randomly mutagenized ssTorA (Supplementary Figure 4).
Chloramphenicol acetyl transferase (CAT) was used as a fusion
partner for the ssTorA library reasoning that ssTorA/CAT can
only confer resistance toward the antibiotic chloramphenicol
when expressed in soluble form (Maxwell et al., 1999). Hence,
only cells with mutant ssTorA that has lost its capacity to
deposit CAT in inclusion bodies are expected to grow on
chloramphenicol containing plates.
First, we confirmed that CAT is expressed in IBs when fused to
wild-type ssTorA (Supplementary Figure 5, lane 6), whereas the
majority of fusion protein remains soluble when a non-functional
variant [ssTorA(N
′
)] is used (Supplementary Figure 5, lane
2). Next, we determined the conditions that allow on-plate
discrimination between cells expressing the soluble and insoluble
CAT fusions. To ensure optimal protein expression and IB
formation cells were first grown and induced in liquid culture
before being spread on LB-plates containing chloramphenicol for
overnight selection of resistant cells (Supplementary Figure 4).
When testing cells expressing either insoluble ssTorA/CAT
or soluble ssTorA(N
′
)/CAT on plates without the antibiotic,
growth was observed in both cases (Supplementary Figure 5B).
In contrast, growth on LB-agar supplemented with 30µg/ml
chloramphenicol yielded colonies only for the cells expressing
the soluble ssTorA(N
′
)/CAT fusion (Supplementary Figure 5B),
providing proof of concept for the screening assay.
Next, we fused a library of randomly mutagenized ssTorA
fragments to CAT and used the on-plate chloramphenicol
survival assay to select for cells that express soluble ssTorA/CAT
mutants. Next-generation sequencing was used to define the
mutations in individual ssTorA encoding DNA fragments
(Supplementary Figure 4). In our analysis we focused on a
138 bp sequence including 21 upstream bases that contain
the ribosome binding site. Interestingly, mutation hotspots
were identified in DNA obtained from chloramphenicol
resistant cells for the R11, R12, L15, L18, and G19 codons
(Supplementary Figure 6). In all these cases the mutations were
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FIGURE 7 | Favored and non-favored substitutions for interference with IB tag
functionality. Amino acids in the ssTorA tag predicted to be important for IB
formation—as based on data displayed in Supplementary Figure 6—are
colored blue. For each of these amino acids, substituting residues potentially
interfering with ssTorA tag functionality—as based on data displayed in
Supplementary Figure 7—are colored red. Substituting residues predicted
to keep tag functionality unaffected are displayed in green.
in the second nucleotide of the codons, consequently resulting in
amino acid substitutions. Importantly, the detected bias against
mutagenesis in the Shine-Dalgarno sequence, which is needed for
efficient expression of ssTorA/CAT, is consistent with the validity
of the screening procedure. Taken together, we identified R11,
R12, L15, L18, and G19 of ssTorA as potentially critical residues
for IB formation (Figure 7).
A bias for specific changes in the mutational hotspots
suggested amino acid substitutions potentially responsible for
enhanced ssTorA/CAT solubility (Supplementary Figure 7). To
further validate the screening procedure and analyze the
importance of R11, R12, L15, L18, and G19 these residues
were individually replaced with the selected residues (Figure 7).
Using the same conditions as above, all mutants indeed induced
a chloramphenicol-resistant phenotype in E. coli on plate
(Supplementary Figure 8), implying expression of ssTorA/CAT
in a (partially) soluble fashion.
Next, we analyzed the solubility of the mutant fusion proteins
using the sedimentation assay (Figure 8). Impaired IB formation
compared to non-mutated ssTorA/CAT (Figure 8, lanes 19–33)
could be confirmed for L15, L18, and G19 mutants, which
were recovered largely in the soluble fraction (Figure 8, lanes
19–33). In contrast, changes at R11 and R12 did not clearly
affect IB formation despite the use of rather non-conserved
substitutions (Figure 8, c.f. lanes 1–15 and 16–18). As a control,
we also substituted L15, L18, and G19 with residues that were
expected not to interfere with the functionality of the tag
based on the Next-generation sequencing analysis (Figure 7;
Supplementary Figure 7). Indeed, the resulting ssTorA/CAT
fusions (M15, Q17, I18, V18, and G19) accumulated almost
exclusively in IBs (Supplementary Figure 9A). Together, these
data suggest that our method effectively discriminates between
solubilizing and non-solubilizing mutations in ssTorA/CAT.
To exclude that our findings were specific for fusions
to CAT, the same substitutions were tested in the context
of a second cargo protein, TrxA, with very similar
results (Supplementary Figures 9B, 10). Whereas mutation of
positions R11 and R12 did not affect IB formation
(Supplementary Figure 10, c.f. lanes 1–15 and 16–18),
substitutions at positions 15, 18, or 19 resulted in elevated
levels of soluble ssTorA/TrxA (Supplementary Figure 10, c.f.
lanes 19–33 and 37–39) except for M15, Q17, I18, V18, and
G19 (Supplementary Figure 9B). In conclusion, our combined
mutagenesis and screening approach identified five potentially
important residues for ssTorA-mediated IB formation. Three of
these (L15, L17, and G19) were confirmed to be critical using IB
sedimentation analysis.
Tandem-Fused Truncated ssTorA Enhance
IB Formation
Previously, we have shown that suboptimal deposition of
cargo proteins in IBs could be enhanced by fusing three
ssTorA in tandem [ssTorA(3X)] (Jong et al., 2017). Since for
biotechnological applications a short IB tag is preferred, a
triple tag of reduced length was made by linking three ssTorA
sequences lacking residues 29–36, which appeared dispensable
for IB formation (see under Regions Critical for IB Formation)
(Supplementary Table 1). To test ssTorA(129/36|3x) it was
not only fused to TrxA but also to another highly soluble
E. coli protein, MBP, and to a small recombinant protein
of human origin, hEGF. All fusion proteins were almost
exclusively detected in the insoluble pellet upon sedimentation
of IBs (Figure 9A, lanes 8, 11, 14), demonstrating that
ssTorA(129/36|3x) indeed functions as an IB formation tag with
a higher efficiency than single ssTorA(129/36). Surprisingly,
when compared side-by-side to TrxA and MBP carrying full-
length ssTorA(3X), fusions to the new truncated tag were
expressed at a higher level (Figure 9A, c.f. lanes 7 and 1;
c.f. lanes 10 and 4) and yielded higher amounts of fusion
protein in IBs (Figure 9A, c.f. lanes 8 and 2; c.f. lanes
11 and 5). Consistently, analysis of cells by phase contrast
microscopy showed more pronounced IB structures for the
fusions carrying the truncated triple tag (Figure 9B). To exclude
that the altered (E. coli optimized) codon usage of the synthetic
ssTorA(129/36|3x) coding sequence is responsible for the effect,
ssTorA(129/36|3x; NO) with a codon usage identical to that
of the full length ssTorA(3X) (Supplementary Figure 2A) was
shown to induce similar elevated expression and IB yields
(Supplementary Figure 2B). In conclusion, the shortened triple
fusion tag has improved IB-formation properties compared to the
original ssTorA(3X) sequence.
DISCUSSION
Previously, we have shown that fusion of heterologous protein to
the signal sequence of TorA did not promote targeting but rather
deposition of the fusion proteins in insoluble aggregates (Jong
et al., 2017). In fact, ssTorA proved to be useful as a small tag for
robust inclusion body formation of even highly soluble proteins.
In this study we characterized the requirements for inclusion
body induction leading to a shortened and improved tag.
As ssTorA is a Tat signal sequence we considered the
possibility that targeting of the fusion protein to the Tat
translocon combined with its translocation incompetence might
increase the local concentration at the membrane and nucleate
aggregation. However, neither the invariant twin arginine (RR)
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FIGURE 8 | Influence of potential solubilizing substitutions on IB formation of ssTorA/CAT. IB-sedimentation assay as described in the legend to Figure 1 on cells
expressing ssTorA/CAT derivatives carrying the indicated single amino acid substitutions in the ssTorA moiety. ssTorA/CAT carrying wild-type ssTorA and CAT lacking
ssTorA (CAT ) were analyzed in parallel as controls. Bands representing fusion proteins of interest are indicated (). Molecular mass (kDa) markers are indicated at the
left side of the panels.
FIGURE 9 | IB formation upon fusion to tandem-fused truncated ssTorA. (A) IB-sedimentation assay as described in the legend to Figure 1 on cells expressing TrxA,
MBP, or hEGF fused to either ssTorA(3X) or ssTorA (129–36|3X) as indicated. Bands representing the fusions of interest are indicated (). (B) Phase-contrast
microscopy on a selection of cells from A as indicated. Examples of IBs are indicated with white arrowheads. Scale bar 2µm.
motif for Tat signal sequences nor the presence of a functional
Tat translocation machinery in the bacterial inner membrane
appeared critical for IB formation (see Figure 1). Additionally,
eleven other Tat signal sequences of varying architecture did not
induce aggregation, except for ssCueO that displays relatively
low similarity to ssTorA. IB formation appeared also unrelated
to the existence of a cognate cytosolic chaperone since ssDmsA,
which also binds a chaperone and is very similar to ssTorA
in function and length (Shanmugham et al., 2012), does not
produce aggregates of fused cargo protein (see Figure 2). This all
suggests that the IB formation properties are contained in unique
sequence characteristics of ssTorA rather than being related to its
physiological role.
Using a systematic deletion approach (Figures 4, 6) we could
limit the region of ssTorA predominantly responsible for IB
formation to residues 10–28. Yet, the presence of residues
2–9 appeared to enhance aggregation efficiency probably by
facilitating optimal translation initiation as a consequence of
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high A/T codon usage (Qing et al., 2003). Based on the
deletion analysis we designed a truncated ssTorA triple fusion
tag lacking residues 29–36 [ssTorA(129/36|3x)]. The truncated
triple tag proved to be superior to the original triple tag
comprising three full-length copies of ssTorA (Jong et al.,
2017) with respect to fusion protein yield and IB formation
(see Figure 9). Interestingly, the deletion removes two prolines
and two arginines per ssTorA copy, residues that have been
reported to promote stalling of nascent polypeptide chains in the
ribosomal exit tunnel (Elgamal et al., 2014; Woolstenhulme et al.,
2015).
Unbiased genetic screening of a library of randomly
mutagenized ssTorA sequences for reduced aggregation
properties using a assay allowed us to pinpoint residues that are
critical for induction of IB formation. Importantly, the location
of these residues was in agreement with the essential region for IB
formation as identified by deletion mutagenesis (see Figure 6).
Moreover, three of the five residues were also demonstrated
to be critical for IB formation upon growth in culture (see
Figure 8). This apparent discrepancy between the sedimentation
procedure and the on-plate chloramphenicol-survival assay may
be due to faster cell growth in the former, slightly favoring IB
formation of ssTorA fusions with close-to-threshold aggregation
properties. Although the focus was on our IB-formation tag,
the presented screening methodology may be more generally
applicable for studying protein aggregation in microbial
model systems.
Prevailing mechanisms for the initiation of aggregation
involve the exposition of hydrophobic stretches that interact with
neighboring protein sequences and/or more specific stacking
of β-strands that nucleates the formation of amyloid-like
cross β-structures (Fink, 1998; Garcia-Fruitos et al., 2011;
Bednarska et al., 2013). However, ssTorA neither possesses
strong hydrophobicity (Tullman-Ercek et al., 2007) nor has
predicted propensity to form β-aggregates (Fernandez-Escamilla
et al., 2004) (data not shown). Formation of an amyloid
structure by a peptide that maintained its α-helical conformation
was recently presented (Tayeb-Fligelman et al., 2017), but it
is hard to envision such a model for ssTorA when fused
to cargos of substantial size. We did, however, identify a
hydrophobic patch that may form when the ssTorA attains
an α-helical conformation. Introduction of a proline indeed
impaired IB formation (see Supplementary Figure 3) and
disruptive proline substitutions (L15P and L18P) were also
selected in our unbiased screening assay, suggesting the
importance of helix formation (see Figures 7, 8). Intermolecular
interactions between the hydrophobic patches on respective
ssTorAs are expected to be insufficient to nucleate IB formation
as only two molecules would be able to associate in this
fashion. On the other hand, this could be sufficient to
hamper folding of the juxtaposed cargo proteins, leading to
exposure of aggregation prone sequences. Consistent with
such an indirect mechanism, the efficiency of IB formation
varies depending on the nature of the fused cargo protein
(e.g., see Supplementary Figure 9).
Co-overexpression of ssTorA fusions with its cognate
cytosolic chaperone TorD prevented IB-formation suggesting
that TorD covers a critical aggregation feature (see Figure 3).
Two-hybrid analysis indeed localized the signal sequence-
binding site of a TorD family chaperone to the Tat-consensus
sequence (see Figure 1A) and several residues downstream
(Coulthurst et al., 2012), which is located in the region identified
in this study as being critical for IB formation. Possibly, TorD
has a similar role under physiological conditions, preventing
aggregation of TMAO-reductase in the bacterial cytoplasm
prior to translocation across the cell envelope (Hatzixanthis
et al., 2005). Similarly, overexpression of DnaK was found to
impair sedimentation of fusion proteins (see Figure 3) and a
predicted binding site in ssTorA (residues 12–18) (Van Durme
et al., 2009) appears to be included in the IB-formation motif.
Conceivably, the motif must be exposed to trigger IB formation.
Alternatively, considering the generic role of DnaK in protein
folding (Kim et al., 2013), strong overexpression of ssTorA may
sequester DnaK from the cytoplasm inducing aggregation of
fused cargo proteins.
In conclusion, the data provided detailed insight into regions
and residues of ssTorA that are critical for its functioning
as an IB formation tag. Furthermore, this study yielded an
improved truncated version of the ssTorA tag that may be
exploited for insoluble protein production in biotechnological
and biomedical applications.
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